Palo Alto Investors’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
187,911
-136,121
| -42% | -$587K | 0.17% | 39 |
|
|
2025
Q1 | $1.21M | Sell |
324,032
-3,101
| -0.9% | -$11.6K | 0.23% | 33 |
|
|
2024
Q4 | $3.32M | Sell |
327,133
-13,013
| -4% | -$132K | 0.51% | 22 |
|
|
2024
Q3 | $4.23M | Hold |
340,146
| – | – | 0.55% | 23 |
|
|
2024
Q2 | $4.43M | Hold |
340,146
| – | – | 0.51% | 26 |
|
|
2024
Q1 | $7.7M | Hold |
340,146
| – | – | 0.87% | 23 |
|
|
2023
Q4 | $4.41M | Sell |
340,146
-38,246
| -10% | -$496K | 0.4% | 25 |
|
|
2023
Q3 | $7.61M | Hold |
378,392
| – | – | 0.72% | 17 |
|
|
2023
Q2 | $10.2M | Hold |
378,392
| – | – | 0.82% | 17 |
|
|
2023
Q1 | $22.1M | Buy |
378,392
+1,347
| +0.4% | +$78.6K | 1.83% | 13 |
|
|
2022
Q4 | $19.2M | Buy |
377,045
+2,276
| +0.6% | +$116K | 1.64% | 11 |
|
|
2022
Q3 | $30.7M | Hold |
374,769
| – | – | 2.43% | 11 |
|
|
2022
Q2 | $25.4M | Hold |
374,769
| – | – | 2.21% | 12 |
|
|
2022
Q1 | $41.4M | Buy |
374,769
+10,072
| +3% | +$1.11M | 3.2% | 11 |
|
|
2021
Q4 | $35.2M | Buy |
364,697
+5,827
| +2% | +$562K | 2.25% | 14 |
|
|
2021
Q3 | $31.3M | Hold |
358,870
| – | – | 1.89% | 15 |
|
|
2021
Q2 | $55.6M | Buy |
358,870
+1,293
| +0.4% | +$200K | 3.06% | 14 |
|
|
2021
Q1 | $56.4M | Buy |
357,577
+6,400
| +2% | +$1.01M | 3.22% | 13 |
|
|
2020
Q4 | $81.5M | Buy |
351,177
+12,100
| +4% | +$2.81M | 4.27% | 8 |
|
|
2020
Q3 | $74.3M | Buy |
339,077
+57,780
| +21% | +$12.7M | 4.08% | 10 |
|
|
2020
Q2 | $79.9M | Sell |
281,297
-5,363
| -2% | -$1.52M | 4.8% | 9 |
|
|
2020
Q1 | $82.6M | Sell |
286,660
-19,673
| -6% | -$5.67M | 6.92% | 6 |
|
|
2019
Q4 | $88.1M | Sell |
306,333
-16,477
| -5% | -$4.74M | 4.85% | 10 |
|
|
2019
Q3 | $46.6M | Sell |
322,810
-28,008
| -8% | -$4.04M | 3.1% | 15 |
|
|
2019
Q2 | $31.5M | Hold |
350,818
| – | – | 1.53% | 19 |
|
|
2019
Q1 | $30.7M | Buy |
350,818
+38,461
| +12% | +$3.37M | 1.28% | 19 |
|
|
2018
Q4 | $43.9M | Buy |
312,357
+1,469
| +0.5% | +$206K | 2.34% | 14 |
|
|
2018
Q3 | $79.4M | Hold |
310,888
| – | – | 3.21% | 12 |
|
|
2018
Q2 | $79.2M | Buy |
310,888
+65,556
| +27% | +$16.7M | 3.17% | 12 |
|
|
2018
Q1 | $49.4M | Buy |
245,332
+9,036
| +4% | +$1.82M | 2.11% | 16 |
|
|
2017
Q4 | $34M | Buy |
236,296
+3,057
| +1% | +$440K | 1.47% | 19 |
|
|
2017
Q3 | $38.4M | Buy |
233,239
+2,067
| +0.9% | +$340K | 1.62% | 19 |
|
|
2017
Q2 | $31.4M | Buy |
231,172
+4,074
| +2% | +$553K | 1.47% | 18 |
|
|
2017
Q1 | $43.7M | Buy |
227,098
+13,738
| +6% | +$2.65M | 2.07% | 16 |
|
|
2016
Q4 | $30.1M | Buy |
213,360
+7,637
| +4% | +$1.08M | 1.72% | 19 |
|
|
2016
Q3 | $30M | Sell |
205,723
-3,573
| -2% | -$521K | 1.74% | 19 |
|
|
2016
Q2 | $21.1M | Buy |
209,296
+2,753
| +1% | +$277K | 1.59% | 19 |
|
|
2016
Q1 | $27.6M | Sell |
206,543
-967
| -0.5% | -$129K | 2.15% | 14 |
|
|
2015
Q4 | $41.2M | Buy |
207,510
+1,794
| +0.9% | +$357K | 2.3% | 12 |
|
|
2015
Q3 | $32.5M | Buy |
205,716
+90,281
| +78% | +$14.3M | 1.56% | 12 |
|
|
2015
Q2 | $47.1M | Buy |
115,435
+52,033
| +82% | +$21.2M | 2.09% | 13 |
|
|
2015
Q1 | $29.1M | Buy |
+63,402
| New | +$29.1M | 1.44% | 14 |
|